신규 의약품 : 세계 시장

The report provides an overview of the global emerging drugs and analyzes market trends, segmented by molecule type, product type, therapeutic application, and end user. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.

Report Scope

The report analyzes the trends in the global emerging drugs market. It includes global revenue ($ billions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented by molecule type (small molecules, biologics and biosimilars, other molecule types), by product type (branded drugs and generic drugs), by therapeutic application (oncology, immunology, cardiovascular, other therapeutic applications), and by end users (hospitals and specialty clinics, pharmacies, and other end users). The regions covered in this study are North America, Europe, Asia-Pacific, and the rest of the World (RoW), with market analysis.

The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies. It offers company profiles that cover financials, product portfolios, and recent developments.

Report Includes

• An overview and analysis of the global emerging drugs market
• Analyses of global market trends, with revenue data for 2024, estimates for 2025, and projections of CAGRs through 2030
• Estimates of the current market size and revenue growth prospects, accompanied by a market share analysis by molecule type, product type, therapeutic application, end user, and region
• Facts and figures pertaining to market dynamics, including key drivers, restraints, challenges, opportunities, and the impact of macroeconomic factors
• Insights derived from Porter's Five Forces analysis, along with an assessment of market structure and competitive intensity
• Review of the regulatory landscape and approval pathways influencing the development and commercialization of emerging drugs
• Discussion of emerging technologies and developments, including advancements in small molecules, biologics, biosimilars, and cell and gene therapies
• Patent review highlighting key granted and published patents related to emerging drug development
• Analysis of the competitive landscape, including company market share rankings, strategic initiatives, and venture funding activity
• Overview of sustainability trends and ESG developments in the global emerging drugs market
• Company profiles of the leading players

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Analysis
• Emerging Technologies
• Conclusion

Chapter 2 Market Overview

• Overview
• Macroeconomic Factors
• Porter's Five Forces Analysis

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Regulatory Acceleration and Supportive Innovation Pathways
• Rising Burden of Chronic Diseases and Ageing Population
• Increasing R&D Investment and Sustained Capital Formation
• Market Restraints
• Complexity of Manufacturing and Supply Chain Challenges
• Pricing and Reimbursement Pressures, Limiting Market Access and Revenue Realization
• Market Opportunities
• Increasing Focus on Rare Diseases and Orphan Drug Development
• Growth of Advanced Modalities: Cell, Gene, and RNA Therapies

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologiesand Developments

• Key Takeaways
• Next-Generation Therapeutic Modalities and Platform Technologies
• Artificial Intelligence (AI)-Driven Drug Discovery and Clinical Development Optimization
• Precision Medicine, Biomarkers, and Companion Diagnostics
• Advanced Manufacturing and Scalable Production Technologies

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Molecule Type
• Key Takeaways
• Small Molecules
• Biologics and Biosimilars
• Other Molecule Types
• Market Analysis by Product Type
• Key Takeaways
• Branded Drugs
• Generic Drugs
• Market Analysis by Therapeutic Application
• Key Takeaways
• Oncology
• Immunology
• Cardiovascular
• Other Therapeutic Applications
• Market Analysis by End User
• Key Takeaways
• Hospitals and Specialty Clinics
• Pharmacies
• Other End Users
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Analysis
• Strategic Initiatives
• Mergers and Acquisitions
• Collaborations

Chapter 8 Appendix

• Research Methodology
• Sources
• Abbreviations
• Company Profiles
• AMGEN INC.
• BRISTOL-MYERS SQUIBB CO.
• F. HOFFMANN-LA ROCHE LTD.
• JOHNSON & JOHNSON
• LILLY USA LLC.
• MERCK & CO. INC.
• NOVARTIS AG
• PFIZER INC.
• REGENERON PHARMACEUTICALS INC.
• VERTEX PHARMACEUTICALS INC.